Article
Clinical and functional evidence for the pathogenicity of the LRRK2 p.Arg1067Gln variant
2024-09-17
Abstract excerpt
<title>Abstract</title> <p>LRRK2-related Parkinson’s disease (LRRK2-PD) is the most frequent form of monogenic PD worldwide, with important therapeutic opportunities, exemplified by the advancement in LRRK2 kinase inhibition studies/trials. However, many LRRK2 variants, especially those found in underrepresented populations, remain classified as variants of uncertain significance (VUS). Leveraging on Malaysian, S...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 80e3a397-6c4d-576c-8371-621a82c2a542
- DOI
- 10.21203/rs.3.rs-4920792/v1
